ELI LILLY & Co: Earnings roundup: Lilly's unwavering momentum, Novartis' rebound and GSK's waiting game · Ereignisanalyse & Evidenz

ELI LILLY & Co: Earnings roundup: Lilly's unwavering momentum, Novartis' rebound and GSK's waiting game · Ereignisanalyse & Evidenz · BoerseAI

Ereignis wird geladen …